Niel Starksen
Founder at VivaLnk, Inc.
Profile
Niel F.
Starksen was the founder of Ancora Heart, Inc. (founded in 2002) where he held the title of President & Chief Executive Officer from 2011 to 2015.
He is also the founder of VivaLnk, Inc. (founded in 2018) where he currently holds the title of Director.
Dr. Starksen's current job is as a Member-Governor Board at The Johns Hopkins Wilmer Eye Institute.
He previously worked as a Director at Arstasis, Inc. and as Chief Scientific Officer at Genesis Unicorn Capital Corp.
Dr. Starksen received his undergraduate degree from the University of California, Irvine in 1978 and his doctorate degree from The Johns Hopkins University School of Medicine in 1982.
Niel Starksen active positions
| Companies | Position | Start |
|---|---|---|
VivaLnk, Inc.
 VivaLnk, Inc. Electronic Production EquipmentElectronic Technology VivaLnk, Inc. delivers comfortable wireless electronic patches that bring users continuous health monitoring and information with effortless grace. It provides supporting healthcare services, such as alerting potential health issues through continuous remote temperature monitoring or improving athletic performance through heart rate monitoring. The company was founded in 2014 and is headquartered in Santa Clara, CA. | Founder | 01/09/2018 |
| The Johns Hopkins Wilmer Eye Institute | Director/Board Member | - |
Former positions of Niel Starksen
| Companies | Position | End |
|---|---|---|
Ancora Heart, Inc.
 Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Chief Executive Officer | 01/07/2015 |
| GENS UNICPAR | Chief Tech/Sci/R&D Officer | - |
Arstasis, Inc.
 Arstasis, Inc. Electronic Equipment/InstrumentsElectronic Technology Arstasis, Inc. develops and manufactures medical devices for femoral catheterizations. It offers AXERA access device, a vascular access device that is used in patients undergoing diagnostic femoral artery catheterization procedures using 5F or 6F introducer sheaths. The company was founded in August 2004 by D. Bruce Modesitt and is headquartered in Fremont, CA. | Director/Board Member | - |
Training of Niel Starksen
| University of California, Irvine | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |
Arstasis, Inc.
Arstasis, Inc. Electronic Equipment/InstrumentsElectronic Technology Arstasis, Inc. develops and manufactures medical devices for femoral catheterizations. It offers AXERA access device, a vascular access device that is used in patients undergoing diagnostic femoral artery catheterization procedures using 5F or 6F introducer sheaths. The company was founded in August 2004 by D. Bruce Modesitt and is headquartered in Fremont, CA. | Electronic Technology |
VivaLnk, Inc.
VivaLnk, Inc. Electronic Production EquipmentElectronic Technology VivaLnk, Inc. delivers comfortable wireless electronic patches that bring users continuous health monitoring and information with effortless grace. It provides supporting healthcare services, such as alerting potential health issues through continuous remote temperature monitoring or improving athletic performance through heart rate monitoring. The company was founded in 2014 and is headquartered in Santa Clara, CA. | Electronic Technology |
| The Johns Hopkins Wilmer Eye Institute | |
Genesis Unicorn Capital Corp.
 Genesis Unicorn Capital Corp. Financial ConglomeratesFinance Genesis Unicorn Capital Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 23, 2021 and is headquartered in Princeton, NJ. | Finance |
- Stock Market
- Insiders
- Niel Starksen
